[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure
Cormorant Asset Management, LP and Bihua Chen have filed an Amended Passive Investment Disclosure (SCHEDULE 13G/A) for BRIGHT MINDS BIOSCIENCES INC. They report shared beneficial ownership of 950,000 common shares, representing 9.71% of the class. The filing indicates 9,787,161 Common Shares outstanding as of February 12, 2026, held through Cormorant Global Healthcare Master Fund, LP.
How this was made
The 30-second read
Why it matters
While passive ownership disclosures can signal institutional confidence, they typically do not cause immediate market reactions unless accompanied by active trading or news.
Market read
The filing has moderate relevance for traders interested in institutional ownership trends within the biotech sector.
What to watch
Potential for future active buying or other news to influence stock; current passive filing alone offers limited actionable insight.
Background
The filing indicates that Cormorant Asset Management and Bihua Chen have increased their passive stake in Bright Minds Biosciences Inc., holding approximately 9.71% of the company's shares.
Ticker impact
The filing indicates a significant passive ownership stake in Bright Minds Biosciences Inc., which could influence market perception.
Moderate upward pressure expected in the short term.
Passive ownership disclosures often reflect institutional interest; however, without active buying signals, the impact may be limited.
The filing's relevance is moderate due to the passive nature of the ownership change.
Minimal to no immediate price movement expected.
Passive filings are common and usually do not trigger significant trading activity unless accompanied by active buying.
Market effects
Potential positive sentiment in biotech and life sciences sectors due to increased institutional interest.
Limited regional impact; primarily relevant to US markets.
Low; specific to company and sector.
Counterpoint
Passive ownership increase may not translate into positive price movement; market may have already priced in institutional interest.
Key entities
- CompanyBright Minds Biosciences Inc.
A biotech company focused on developing innovative therapies.
- Institutional InvestorCormorant Asset Management, LP
A healthcare-focused investment firm.
- InvestorBihua Chen
An individual or institutional investor involved in the filing.
